The importance of CD23 in mediating allergen-presentation in the context of allergy is also supported by the fact that application of the anti-CD23 monoclonal antibody lumiliximab to allergen-stimulated PBMC cultures reduced their proliferation to allergen in vitro by 50% (66). Here, FCER2 is linked to Allergy.